Tech Company Financing Transactions
AdipoPharma Funding Round
AdipoPharma secured a funding round on 11/12/2024. Investors included Good Growth Capital, InvestSud and Newton Biocapital.
Transaction Overview
Company Name
Announced On
11/12/2024
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to accelerate its clinical development.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Parc d'Innovation 650 Boulevard Gonthier d'Andernach
Illkirch-Graffenstaden, 67400
FR
Illkirch-Graffenstaden, 67400
FR
Phone
Undisclosed
Website
Email Address
Overview
AdipoPharma SAS is a French biotech company committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis. The company was created to commercialize the work of its founder, Dr. Vincent Marion PhD, MSc, and Biochemist and researcher at INSERM, the French National Institute for Health and Medical Research. Dr Marion's team has spent more than a decade identifying therapeutic targets based on the adipocyte's specific role in the metabolic effects of insulin resistance and diabetes. This work began by the detailed genetic investigation of Alström syndrome, an ultra-rare devastating disease characterized by severe insulin resistance, early-onset type 2 diabetes and associated metabolic dysfunctions.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 11/12/2024: Neo Financial venture capital transaction
Next: 11/12/2024: Alentis Therapeutics venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs